| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | supercoiled DNA binding | 2.44e-05 | 6 | 26 | 2 | GO:0097100 | |
| GeneOntologyMolecularFunction | RAGE receptor binding | 1.69e-04 | 15 | 26 | 2 | GO:0050786 | |
| GeneOntologyMolecularFunction | four-way junction DNA binding | 2.75e-04 | 19 | 26 | 2 | GO:0000400 | |
| GeneOntologyMolecularFunction | DNA binding, bending | 3.05e-04 | 20 | 26 | 2 | GO:0008301 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 3.71e-04 | 22 | 26 | 2 | GO:0050321 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 5.97e-04 | 303 | 26 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 6.99e-04 | 562 | 26 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 9.33e-04 | 149 | 26 | 3 | GO:0030295 | |
| GeneOntologyMolecularFunction | kinase activator activity | 1.13e-03 | 159 | 26 | 3 | GO:0019209 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 1.30e-03 | 41 | 26 | 2 | GO:0000217 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 1.42e-03 | 43 | 26 | 2 | GO:0008307 | |
| GeneOntologyMolecularFunction | tau protein binding | 1.63e-03 | 46 | 26 | 2 | GO:0048156 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 1.78e-03 | 1418 | 26 | 7 | GO:0030234 | |
| GeneOntologyMolecularFunction | chemoattractant activity | 2.24e-03 | 54 | 26 | 2 | GO:0042056 | |
| GeneOntologyMolecularFunction | pentosyltransferase activity | 2.40e-03 | 56 | 26 | 2 | GO:0016763 | |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 4.50e-03 | 259 | 26 | 3 | GO:0019887 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 4.61e-03 | 78 | 26 | 2 | GO:0043539 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 5.32e-03 | 84 | 26 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | myosin binding | 5.45e-03 | 85 | 26 | 2 | GO:0017022 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 7.07e-03 | 305 | 26 | 3 | GO:0019207 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 8.20e-03 | 105 | 26 | 2 | GO:0004867 | |
| GeneOntologyCellularComponent | dendritic growth cone | 9.74e-05 | 12 | 26 | 2 | GO:0044294 | |
| GeneOntologyCellularComponent | dendrite terminus | 2.79e-04 | 20 | 26 | 2 | GO:0044292 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.43e-03 | 45 | 26 | 2 | GO:0044295 | |
| MousePheno | failure of neuromuscular synapse postsynaptic differentiation | 3.53e-05 | 6 | 22 | 2 | MP:0001055 | |
| Domain | SSU_processome_Utp14 | 1.86e-06 | 2 | 26 | 2 | IPR006709 | |
| Domain | Utp14 | 1.86e-06 | 2 | 26 | 2 | PF04615 | |
| Domain | HMG_boxA_CS | 5.59e-06 | 3 | 26 | 2 | IPR017967 | |
| Domain | HMG_box | 5.36e-05 | 53 | 26 | 3 | PF00505 | |
| Domain | HMG | 5.67e-05 | 54 | 26 | 3 | SM00398 | |
| Domain | HMG_box_2 | 6.67e-05 | 9 | 26 | 2 | PF09011 | |
| Domain | HMG_BOX_1 | 8.33e-05 | 10 | 26 | 2 | PS00353 | |
| Domain | HMG_box_dom | 9.88e-05 | 65 | 26 | 3 | IPR009071 | |
| Domain | Serpin_CS | 9.01e-04 | 32 | 26 | 2 | IPR023795 | |
| Domain | Serpin_dom | 1.14e-03 | 36 | 26 | 2 | IPR023796 | |
| Domain | SERPIN | 1.20e-03 | 37 | 26 | 2 | PS00284 | |
| Domain | SERPIN | 1.20e-03 | 37 | 26 | 2 | SM00093 | |
| Domain | Serpin | 1.27e-03 | 38 | 26 | 2 | PF00079 | |
| Domain | Serpin_fam | 1.34e-03 | 39 | 26 | 2 | IPR000215 | |
| Domain | HMG_BOX_2 | 2.55e-03 | 54 | 26 | 2 | PS50118 | |
| Domain | - | 2.64e-03 | 55 | 26 | 2 | 1.10.30.10 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 5.80e-05 | 49 | 22 | 3 | MM15448 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 6.94e-05 | 52 | 22 | 3 | M2341 | |
| Pathway | BIOCARTA_DNAFRAGMENT_PATHWAY | 1.04e-04 | 10 | 22 | 2 | M7239 | |
| Pathway | BIOCARTA_DNAFRAGMENT_PATHWAY | 1.27e-04 | 11 | 22 | 2 | MM1349 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 1.52e-04 | 12 | 22 | 2 | MM14554 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 1.79e-04 | 13 | 22 | 2 | M1018 | |
| Pathway | REACTOME_APOPTOSIS | 6.06e-04 | 108 | 22 | 3 | MM14471 | |
| Pathway | PID_P38_MKK3_6PATHWAY | 7.39e-04 | 26 | 22 | 2 | M20 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 1.34e-03 | 142 | 22 | 3 | MM15178 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.34e-03 | 35 | 22 | 2 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.42e-03 | 36 | 22 | 2 | M18647 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 1.58e-03 | 38 | 22 | 2 | M39549 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 10499552 | ||
| Pubmed | Testosterone suppresses spermatogenesis in juvenile spermatogonial depletion (jsd ) mice. | 5.37e-07 | 2 | 26 | 2 | 11466222 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 9016958 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 22644337 | ||
| Pubmed | shRNA off-target effects in vivo: impaired endogenous siRNA expression and spermatogenic defects. | 5.37e-07 | 2 | 26 | 2 | 25790000 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 11168646 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 28830982 | ||
| Pubmed | Association of HMGB1 and HMGB2 genetic polymorphisms with lung cancer chemotherapy response. | 5.37e-07 | 2 | 26 | 2 | 24684392 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 27863459 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 15496585 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 8599938 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 14500567 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 8339930 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 7607539 | ||
| Pubmed | Non-histone chromosomal proteins HMG1 and 2 enhance ligation reaction of DNA double-strand breaks. | 5.37e-07 | 2 | 26 | 2 | 9600082 | |
| Pubmed | Testosterone inhibits spermatogonial differentiation in juvenile spermatogonial depletion mice. | 5.37e-07 | 2 | 26 | 2 | 11415997 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 28916968 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 11751268 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 19435426 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 38542079 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 17406091 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 25060178 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 18798064 | ||
| Pubmed | Cessation of spermatogenesis in juvenile spermatogonial depletion (jsd/jsd) mice. | 5.37e-07 | 2 | 26 | 2 | 9354954 | |
| Pubmed | Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein Hmgb2. | 5.37e-07 | 2 | 26 | 2 | 11262228 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 1346141 | ||
| Pubmed | Correlation of serum HMGB1 and HMGB2 levels with clinical symptoms in allergic rhinitis children. | 5.37e-07 | 2 | 26 | 2 | 37713866 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 33076532 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 12925773 | ||
| Pubmed | Interactions of HMGB Proteins with the Genome and the Impact on Disease. | 5.37e-07 | 2 | 26 | 2 | 34680084 | |
| Pubmed | The HMG-1 box protein family: classification and functional relationships. | 5.37e-07 | 2 | 26 | 2 | 7784217 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 21733828 | ||
| Pubmed | 5.82e-07 | 1442 | 26 | 9 | 35575683 | ||
| Pubmed | Isolation of a novel cDNA that encodes a protein localized to the pre-acrosome region of spermatids. | 1.61e-06 | 3 | 26 | 2 | 8529672 | |
| Pubmed | Juvenile spermatogonial depletion (jsd): a genetic defect of germ cell proliferation of male mice. | 1.61e-06 | 3 | 26 | 2 | 3401545 | |
| Pubmed | Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades. | 1.61e-06 | 3 | 26 | 2 | 9786855 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 20650881 | ||
| Pubmed | Identification of the core-histone-binding domains of HMG1 and HMG2. | 1.61e-06 | 3 | 26 | 2 | 3697355 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 17475932 | ||
| Pubmed | TAO kinases mediate activation of p38 in response to DNA damage. | 1.61e-06 | 3 | 26 | 2 | 17396146 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 15289605 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 10490593 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 16627582 | ||
| Pubmed | An X-to-autosome retrogene is required for spermatogenesis in mice. | 1.61e-06 | 3 | 26 | 2 | 15258580 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 18239742 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 23585562 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 19136388 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 31621076 | ||
| Pubmed | Arrest of spermatogonial differentiation in jsd/jsd, Sl17H/Sl17H, and cryptorchid mice. | 1.61e-06 | 3 | 26 | 2 | 10456866 | |
| Pubmed | A novel RAG1 mutation reveals a critical in vivo role for HMGB1/2 during V(D)J recombination. | 1.61e-06 | 3 | 26 | 2 | 30538136 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 9722660 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 17291484 | ||
| Pubmed | Molecular mechanism of the RNA helicase DHX37 and its activation by UTP14A in ribosome biogenesis. | 1.61e-06 | 3 | 26 | 2 | 30910870 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 7924983 | ||
| Pubmed | Homeostatic regulation of germinal stem cell proliferation by the GDNF/FSH pathway. | 3.22e-06 | 4 | 26 | 2 | 11900972 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 14739282 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 12517784 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 11099378 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 10497253 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 11748232 | ||
| Pubmed | UTP14c is a recently acquired retrogene associated with spermatogenesis and fertility in man. | 3.22e-06 | 4 | 26 | 2 | 16354793 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 13679851 | ||
| Pubmed | HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha. | 5.37e-06 | 5 | 26 | 2 | 19223331 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 9671457 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 22683681 | ||
| Pubmed | HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. | 5.37e-06 | 5 | 26 | 2 | 19890330 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 2767687 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 18356279 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 19139395 | ||
| Pubmed | Identification of a novel Sry-related gene and its germ cell-specific expression. | 8.05e-06 | 6 | 26 | 2 | 10359848 | |
| Pubmed | The prostate-derived sterile 20-like kinase (PSK) regulates microtubule organization and stability. | 8.05e-06 | 6 | 26 | 2 | 12639963 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 15938716 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 11733032 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 16893890 | ||
| Pubmed | 8.88e-06 | 177 | 26 | 4 | 26206133 | ||
| Pubmed | In vitro acetylation of HMGB-1 and -2 proteins by CBP: the role of the acidic tail. | 1.13e-05 | 7 | 26 | 2 | 15005629 | |
| Pubmed | 2.94e-05 | 11 | 26 | 2 | 15203215 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.00e-05 | 497 | 26 | 5 | 36774506 | |
| Pubmed | 3.41e-05 | 1293 | 26 | 7 | 15342556 | ||
| Pubmed | Molecular diversity of myofibrillar proteins: gene regulation and functional significance. | 3.53e-05 | 12 | 26 | 2 | 8618961 | |
| Pubmed | 4.17e-05 | 13 | 26 | 2 | 11700028 | ||
| Pubmed | An 'equalized cDNA library' by the reassociation of short double-stranded cDNAs. | 4.17e-05 | 13 | 26 | 2 | 2216762 | |
| Pubmed | 6.44e-05 | 1429 | 26 | 7 | 35140242 | ||
| Pubmed | Identification of casein kinase Ialpha interacting protein partners. | 7.26e-05 | 17 | 26 | 2 | 12062430 | |
| Pubmed | 7.26e-05 | 17 | 26 | 2 | 12360237 | ||
| Pubmed | 7.26e-05 | 17 | 26 | 2 | 19690890 | ||
| Pubmed | A functional screen to identify novel effectors of hematopoietic stem cell activity. | 7.26e-05 | 17 | 26 | 2 | 19379700 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 8.59e-05 | 1496 | 26 | 7 | 32877691 | |
| Pubmed | 9.59e-05 | 119 | 26 | 3 | 24162774 | ||
| Pubmed | 1.23e-04 | 22 | 26 | 2 | 21384471 | ||
| Pubmed | 1.47e-04 | 24 | 26 | 2 | 32867128 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 1.49e-04 | 1124 | 26 | 6 | 21900206 | |
| Pubmed | 1.73e-04 | 26 | 26 | 2 | 35920200 | ||
| Pubmed | Spermatogonia-dependent expression of testicular genes in mice. | 2.15e-04 | 29 | 26 | 2 | 12051830 | |
| Pubmed | Isolation and characterization of proteins associated with histone H3 tails in vivo. | 2.31e-04 | 30 | 26 | 2 | 17403666 | |
| Pubmed | Analysis of the Tropism of SARS-CoV-2 Based on the Host Interactome of the Spike Protein. | 2.47e-04 | 31 | 26 | 2 | 37939376 | |
| Pubmed | Interaction proteomics of the HMGA chromatin architectural factors. | 2.63e-04 | 32 | 26 | 2 | 18850631 | |
| Pubmed | Cellular substrates and pro-apoptotic function of the human HtrA4 protease. | 2.89e-04 | 173 | 26 | 3 | 31470122 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 3.51e-04 | 1318 | 26 | 6 | 30463901 | |
| Pubmed | 3.52e-04 | 37 | 26 | 2 | 34225486 | ||
| Interaction | CDC42 interactions | 1.72e-05 | 1323 | 25 | 9 | int:CDC42 | |
| Interaction | UTP14C interactions | 3.18e-05 | 50 | 25 | 3 | int:UTP14C | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q21 | 6.01e-03 | 205 | 26 | 2 | chr18q21 | |
| GeneFamily | Canonical high mobility group | 7.02e-05 | 11 | 21 | 2 | 511 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 3.49e-04 | 24 | 21 | 2 | 654 | |
| GeneFamily | Serpin peptidase inhibitors | 8.35e-04 | 37 | 21 | 2 | 739 | |
| Coexpression | ONDER_CDH1_TARGETS_1_DN | 1.09e-08 | 170 | 25 | 6 | M6822 | |
| Coexpression | GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN | 3.67e-05 | 200 | 25 | 4 | M3664 | |
| ToppCell | Monocytes-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.64e-05 | 85 | 26 | 3 | e73603d6f22bb56159aa5d1a2695775f038e61d8 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 9.84e-05 | 155 | 26 | 3 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Batf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-04 | 157 | 26 | 3 | 921805932f7974d37aed547861d555b07f30aba6 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.41e-04 | 175 | 26 | 3 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 178 | 26 | 3 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.61e-04 | 183 | 26 | 3 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.74e-04 | 188 | 26 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.77e-04 | 189 | 26 | 3 | cce6602ad68c177985a5e43cfb2776d615cfbca0 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-04 | 194 | 26 | 3 | c53478057674d70b79df8a3f476d15dea1925753 | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 1.91e-04 | 194 | 26 | 3 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.91e-04 | 194 | 26 | 3 | 8805c90e4284a81a6c8078f2d2417ae77b4e5c63 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-04 | 194 | 26 | 3 | 86d52467b05a0018517377c9c441245501f71d91 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.91e-04 | 194 | 26 | 3 | 2ab3f75b795a0ee4fe0f8eeba33093fcc77935f5 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.91e-04 | 194 | 26 | 3 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM5|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.94e-04 | 195 | 26 | 3 | 6d768454ed630e586431535400507074eea76dd1 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-04 | 197 | 26 | 3 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.00e-04 | 197 | 26 | 3 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 197 | 26 | 3 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.03e-04 | 198 | 26 | 3 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 198 | 26 | 3 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | COVID-19-Heart-Mito_CM|Heart / Disease (COVID-19 only), tissue and cell type | 2.03e-04 | 198 | 26 | 3 | b6cd439863d17209b86dc50ae51282dc1725955d | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 198 | 26 | 3 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-04 | 198 | 26 | 3 | 7b61f427ed5ca8ad563e5f112fba950a24c9d956 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 198 | 26 | 3 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 199 | 26 | 3 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.06e-04 | 199 | 26 | 3 | c7c501ad144ac5488d0b0496554d46616f2e01a6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.09e-04 | 200 | 26 | 3 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | severe-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.09e-04 | 200 | 26 | 3 | db7046741706376682d164c385c4701aebefc2e6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.09e-04 | 200 | 26 | 3 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | severe-HLA-DR-_S100A+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.09e-04 | 200 | 26 | 3 | a5eb50cbf3e94f0b3aa0fbef888989a11cffea37 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Fibcd1_(ventral_GP_(vGP))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.56e-04 | 48 | 26 | 2 | 63d5d3bbfa9446676d3a53409bc59192abaeabd7 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Fibcd1_(ventral_GP_(vGP))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.56e-04 | 48 | 26 | 2 | 89449efbb229f36d415ca80e5519308997ec106d | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Fibcd1_(ventral_GP_(vGP))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.56e-04 | 48 | 26 | 2 | 6cedbfa330eb1c18d7254cb26ddd5f5d3e6d7359 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocyte.Tnr.Ctps_(Ctps)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.39e-04 | 78 | 26 | 2 | 2b0973122052bb26153f066e7b87c26f8a319698 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.39e-04 | 78 | 26 | 2 | 1ddbb2247450a8b1c159f524dee15bf688748955 | |
| ToppCell | Dendritic_Cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.11e-03 | 85 | 26 | 2 | d2776a2c8d1721dbbd7d5dc868a3810e30dd9064 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Rostral-�migratory_stream-�(RMS)_(Tuba1c))|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.57e-03 | 101 | 26 | 2 | 0b32e6071f05dbe808e51e18c3a3f8221f438f83 | |
| ToppCell | COVID-19-Heart-Fib_+_CM|Heart / Disease (COVID-19 only), tissue and cell type | 1.66e-03 | 104 | 26 | 2 | 0b60a56a46f1fe3f8224ec6399d009a34a117a21 | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.72e-03 | 106 | 26 | 2 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.72e-03 | 106 | 26 | 2 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.72e-03 | 106 | 26 | 2 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| ToppCell | COVID-19-Heart-Fib_+_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.92e-03 | 112 | 26 | 2 | d00ee6b19e41a35450681fe676885983536d6292 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-03 | 127 | 26 | 2 | aca98d8c91f2aa0a777b6e9480c9ea70d38ff393 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.50e-03 | 128 | 26 | 2 | 9ab55a0421cd970e0b8dabce67dd68e382a6bd41 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-03 | 129 | 26 | 2 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-4|TCGA-Uterus / Sample_Type by Project: Shred V9 | 2.61e-03 | 131 | 26 | 2 | 1801611e6b63aa07629e7ccc692f45a7e93c8dd8 | |
| ToppCell | Endothelial-H_(cycle)|World / shred on cell class and cell subclass (v4) | 2.69e-03 | 133 | 26 | 2 | 8e3005114761feee028c496cc739e607b35d7831 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.02e-03 | 141 | 26 | 2 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | BLOOD--(3)_MNP-(3)_Classical_Mono-1|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.06e-03 | 142 | 26 | 2 | 395f80e99be4a0ef07fb9d65c74399e7e67c9a8d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cpa6_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.06e-03 | 142 | 26 | 2 | 84742a7e35bab09ee1cca80cfe120b613d6aed6a | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Gkn1_Pcdh19|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.14e-03 | 144 | 26 | 2 | e8caeb6485f4c8f9a3384570dc69024c2bcc9ab0 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.14e-03 | 144 | 26 | 2 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.19e-03 | 145 | 26 | 2 | 9743d68ba8bfef56fd9a979ab357c0e287eb5ae2 | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-03 | 148 | 26 | 2 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | IIH-CD4-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 3.32e-03 | 148 | 26 | 2 | ec626a44cea83f2a0e5c27fc8182f96446d297ac | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-03 | 148 | 26 | 2 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 3.36e-03 | 149 | 26 | 2 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-8|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 3.36e-03 | 149 | 26 | 2 | 0c18acfc5f0a9dd25ee5c38f97498b3278e65b42 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.36e-03 | 149 | 26 | 2 | 797b5f267e86fbe1d7af99df514d8074446603c6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-03 | 150 | 26 | 2 | 6c39e73a0b05d4b26589f333ce13924e3d373b8d | |
| ToppCell | Severe_COVID-19-undefined|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.45e-03 | 151 | 26 | 2 | 2ae403417fcb3fe402f6f47bb60ffa68d5fefd2a | |
| ToppCell | Severe_COVID-19-undefined-undefined|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.45e-03 | 151 | 26 | 2 | b402185dd7a93c6d0ec5c4d84d5031a157ee8cfb | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.45e-03 | 151 | 26 | 2 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.49e-03 | 152 | 26 | 2 | f748ee34167f79ecda116aa1914afab47403385a | |
| ToppCell | 368C-Myeloid-Mast_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-03 | 152 | 26 | 2 | faf30245a1690aaa27c7be0832797c340e4af4d7 | |
| ToppCell | 368C-Myeloid-Mast_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-03 | 152 | 26 | 2 | 519c9ed05fdaf420e42147ffae1dc05a7f86fdd4 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.63e-03 | 155 | 26 | 2 | 4559e3011514041b65c17ae4ede29da202bce14c | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.68e-03 | 156 | 26 | 2 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-03 | 157 | 26 | 2 | 0673c7161c25feceee8f1e5fd237171576c42c6b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-03 | 157 | 26 | 2 | d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-03 | 158 | 26 | 2 | b3a810314e253b4fd0f578e759c36fdd21722934 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.77e-03 | 158 | 26 | 2 | 9e0589f770920f8ac41cfe5cd0a29e9e7a04a308 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-03 | 158 | 26 | 2 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-03 | 158 | 26 | 2 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-03 | 158 | 26 | 2 | 0ed844ab625351a46b74edddf082279ed1bae5c6 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-03 | 158 | 26 | 2 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.86e-03 | 160 | 26 | 2 | d8241404d775f9a709abdf17988f36293fcf4c58 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.86e-03 | 160 | 26 | 2 | 5cc1b75e3c20d83112b3aa2f3c749a6c73910a2d | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.86e-03 | 160 | 26 | 2 | 8308ca6f37986c526432a0fbc5f7ec2e75cfb6d7 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.91e-03 | 161 | 26 | 2 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.91e-03 | 161 | 26 | 2 | 2b94748b0594ae45ead970fa8d4817e65da999e3 | |
| ToppCell | BL-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.96e-03 | 162 | 26 | 2 | 25ec9df914445b4daae4fd28fd0e60b64797c46d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.96e-03 | 162 | 26 | 2 | 2d28306c6125b31f11ea6d911a167b93a74907c5 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.00e-03 | 163 | 26 | 2 | ed7319185c1ec384444309bb8be95691a0c2091c | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.00e-03 | 163 | 26 | 2 | e6213900f56257fe38ac7852351bea0340294be0 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 4.00e-03 | 163 | 26 | 2 | be774c0ba38fa89a9c0076524cf05d593c6c6826 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.00e-03 | 163 | 26 | 2 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-03 | 163 | 26 | 2 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.00e-03 | 163 | 26 | 2 | ef35d7ff09aa364734fea7fdaab6260c0a3fbf09 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-03 | 164 | 26 | 2 | 2a230ea066decb798a0e6f2b96c7608c8e608031 | |
| ToppCell | 356C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.05e-03 | 164 | 26 | 2 | f7288ec4daf494dae770ea6c58bead27660ccae1 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.05e-03 | 164 | 26 | 2 | 72ef807895385ba23e30d19d12b1b0549a699690 | |
| ToppCell | 356C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.05e-03 | 164 | 26 | 2 | b3192c443f4848e6a8afdb89c155f9ec42a154b0 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-03 | 164 | 26 | 2 | d02d39edd0bfef5a53b814ec6d5f026d41253218 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 4.10e-03 | 165 | 26 | 2 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.10e-03 | 165 | 26 | 2 | 1dcd6b8aa192baeaa1f7bb334843edab6049b96f | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 4.10e-03 | 165 | 26 | 2 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-03 | 165 | 26 | 2 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-03 | 166 | 26 | 2 | 5c132f505dc5f699c87913f140344fc9f8e7e0f5 | |
| Computational | Anti-apoptosis. | 3.55e-04 | 17 | 18 | 2 | MODULE_537 | |
| Computational | Neighborhood of TTN | 8.41e-04 | 26 | 18 | 2 | GNF2_TTN | |
| Computational | Genes in the cancer module 202. | 9.76e-04 | 28 | 18 | 2 | MODULE_202 | |
| Computational | Phosphatase regulators. | 9.76e-04 | 28 | 18 | 2 | MODULE_281 | |
| Computational | Neighborhood of ANP32B | 1.70e-03 | 37 | 18 | 2 | GNF2_ANP32B | |
| Computational | DNA replication. | 2.30e-03 | 43 | 18 | 2 | MODULE_158 | |
| Computational | Viral anti-apoptotic evasion mechanisms. | 2.74e-03 | 47 | 18 | 2 | MODULE_312 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.74e-03 | 47 | 18 | 2 | GAVISH_3CA_METAPROGRAM_B_CELLS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.74e-03 | 47 | 18 | 2 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_CELL_CYCLE | |
| Computational | Genes in the cancer module 387. | 2.97e-03 | 49 | 18 | 2 | MODULE_387 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.97e-03 | 49 | 18 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes in the cancer module 201. | 3.09e-03 | 50 | 18 | 2 | MODULE_201 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.09e-03 | 50 | 18 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_3_CELL_CYLCE_HMG_RICH | |
| Computational | Genes in the cancer module 329. | 3.22e-03 | 51 | 18 | 2 | MODULE_329 | |
| Computational | Neighborhood of DEK | 4.14e-03 | 58 | 18 | 2 | GNF2_DEK | |
| Computational | Genes in the cancer module 254. | 4.43e-03 | 60 | 18 | 2 | MODULE_254 | |
| Disease | central nervous system disease (implicated_via_orthology) | 8.21e-05 | 16 | 25 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.56e-03 | 69 | 25 | 2 | DOID:1682 (implicated_via_orthology) | |
| Disease | Hereditary Diffuse Gastric Cancer | 1.90e-03 | 293 | 25 | 3 | C1708349 | |
| Disease | Stomach Neoplasms | 1.97e-03 | 297 | 25 | 3 | C0038356 | |
| Disease | unipolar depression, alcohol dependence | 1.99e-03 | 78 | 25 | 2 | EFO_0003761, MONDO_0007079 | |
| Disease | Malignant neoplasm of stomach | 2.03e-03 | 300 | 25 | 3 | C0024623 | |
| Disease | Squamous cell carcinoma of esophagus | 2.93e-03 | 95 | 25 | 2 | C0279626 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.32e-03 | 152 | 25 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | squamous cell lung carcinoma | 8.57e-03 | 165 | 25 | 2 | EFO_0000708 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NCKMKFGSWTYDKAK | 196 | Q15822 | |
| KLKTKFISAWNNMKY | 11 | Q96DT6 | |
| CWSYLSTNKKMKSDG | 56 | Q9UPP5 | |
| YTKNQAWKSMKDTLG | 236 | Q8NBL1 | |
| HSKSSQYRKMKTEWK | 4756 | Q8NEZ4 | |
| FSKKCSERWKTMSAK | 41 | P09429 | |
| FSKKCSERWKTMSAK | 41 | P26583 | |
| LWNSYQAKKKTMDAK | 1656 | Q460N5 | |
| ASVETWKYKAKNSLM | 211 | Q96DF8 | |
| SQQDSMKYKDKWATD | 421 | O75128 | |
| MSMSCSWKSDFKKYV | 46 | Q13118 | |
| SAKTKKDNMKYASWA | 246 | Q15006 | |
| ITYDKLNKWTSKDKM | 286 | P05120 | |
| NMTWKIKLKSAMYFS | 161 | P59537 | |
| MWQKNFKRISYAKTK | 101 | Q9BYD3 | |
| MKWSYKSQLNYKTKQ | 131 | Q9NYZ4 | |
| IKKMSYSGKQSTEKW | 56 | Q7L7X3 | |
| IKKMSYSGKQSNEKW | 56 | Q9UL54 | |
| WTNSNKQKMKYDFSC | 31 | Q13490 | |
| DKMKNLSKSWWKKYC | 241 | Q7L0Q8 | |
| SGKWAKSKAIMAKYD | 301 | Q5TAP6 | |
| TKEEKFWMNKSTSKS | 196 | Q9UIV8 | |
| NSGKWAKSKAIMAKY | 301 | Q9BVJ6 | |
| NTKIQMSYSVKWKKS | 186 | Q9HD45 | |
| MLWNKKSNKSNKYSH | 261 | Q9H2Y7 | |
| YTIQKADKKSMEWFT | 966 | Q00872 | |
| SQKLYTKGWDESKMK | 3726 | P20929 |